Cumberland Pharmaceuticals Files Q1 2025 10-Q
Ticker: CPIX · Form: 10-Q · Filed: May 9, 2025 · CIK: 1087294
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
Related Tickers: CPix
TL;DR
CPix Q1 2025 10-Q filed. Financials updated.
AI Summary
Cumberland Pharmaceuticals Inc. filed its 10-Q for the period ending March 31, 2025. The filing details the company's financial performance and position as of Q1 2025. Key financial data and disclosures relevant to investors are presented in this report.
Why It Matters
This filing provides investors with an update on Cumberland Pharmaceuticals' financial health and operational performance for the first quarter of 2025, crucial for investment decisions.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing financial updates, not indicating immediate significant risks.
Key Players & Entities
- CUMBERLAND PHARMACEUTICALS INC (company) — Filer of the 10-Q report
- 20250331 (date) — Conformed period of report
- 20250509 (date) — Filed as of date
- 2525 WEST END AVENUE SUITE 950 (address) — Company's business and mail address
- NASHVILLE, TN 37203 (address) — Company's business and mail city, state, zip
FAQ
What is the reporting period for this 10-Q filing?
The conformed period of report is 20250331, meaning the filing covers the first quarter of 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed as of date 20250509.
What is Cumberland Pharmaceuticals Inc.'s primary business classification?
Cumberland Pharmaceuticals Inc. is classified under STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834].
What is the company's fiscal year end?
The company's fiscal year ends on 1231.
What is the company's SEC file number?
The SEC file number for Cumberland Pharmaceuticals Inc. is 001-33637.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 9, 2025 regarding CUMBERLAND PHARMACEUTICALS INC (CPIX).